People in the News: Trovagene Names Cantor to SAB; WaferGen Hires Two Managers | GenomeWeb

Trovagene said this week that Charles Cantor has joined the company's scientific advisory board.

Cantor is currently adjunct professor of bioengineering at the University of California, San Diego; adjunct professor of molecular biology at the Scripps Research Institute; and distinguished adjunct professor of physiology and biophysics at the University of California, Irvine. He is also professor emeritus of biomedical engineering and pharmacology, and was the director of the Center for Advanced Biotechnology at Boston University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.